Ref­er­ences bya

  1. Lind­man BR, Clav­el MA, Math­ieu P, et al. Cal­cif­ic aor­tic steno­sis. Nat Rev Dis Primers. Mar 3 2016;2:16006. doi:10.1038/nrdp.2016.6
  2. Cof­fey S, Roberts-Thom­son R, Brown A, et al. Glob­al epi­demi­ol­o­gy of valvu­lar heart dis­ease. Nature Reviews Car­di­ol­o­gy. 2021;18(12):853–864.
  3. Nishimu­ra RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guide­line for the man­age­ment of patients with valvu­lar heart dis­ease: a report of the Amer­i­can Col­lege of Cardiology/American Heart Asso­ci­a­tion Task Force on Prac­tice Guide­lines. J Am Coll Car­di­ol. Jun 10 2014;63(22):e57-185. doi:10.1016/j.jacc.2014.02.536.
  4. Lin­droos M, Kupari M, Heikki­la J, Tilvis R. Preva­lence of aor­tic valve abnor­mal­i­ties in the elder­ly: an echocar­dio­graph­ic study of a ran­dom pop­u­la­tion sam­ple. J Am Coll Car­di­ol. Apr 1993;21(5):1220–5. doi:10.1016/0735–1097(93)90249‑z
  5. Ancona, R. Pin­to, SC. Epi­demi­ol­o­gy of aor­tic valve steno­sis (AS) and of aor­tic valve incom­pe­tence (AI): is the preva­lence of AS/AI sim­i­lar in dif­fer­ent parts of the world? e‑Journal of Car­di­ol­o­gy Prac­tice. 2020;18.
  6. Otto CM. Tim­ing of aor­tic valve surgery. Heart. 2000;84(2):211–218.
  7. Ng ACT, Pri­ha­di EA, Antoni ML, et al. Left ven­tric­u­lar glob­al lon­gi­tu­di­nal strain is pre­dic­tive of all-cause mor­tal­i­ty inde­pen­dent of aor­tic steno­sis sever­i­ty and ejec­tion frac­tion. Eur Heart J Car­dio­vasc Imag­ing. Aug 1 2018;19(8):859–867. doi:10.1093/ehjci/jex189.
  8. Klae­boe LG, Haland TF, Leren IS, et al. Prog­nos­tic Val­ue of Left Ven­tric­u­lar Defor­ma­tion Para­me­ters in Patients with Severe Aor­tic Steno­sis: A Pilot Study of the Use­ful­ness of Strain Echocar­dio­g­ra­phy. J Am Soc Echocar­dio­gr. Aug 2017;30(8):727–735.e1. doi:10.1016/j.echo.2017.04.009
  9. Taniguchi T, Mori­mo­to T, Shio­mi H, et al. Sud­den Death in Patients With Severe Aor­tic Steno­sis: Obser­va­tions From the CURRENT AS Reg­istry. J Am Heart Assoc. May 18 2018;7(11)doi:10.1161/jaha.117.008397.
  10. Hudzik B, Wilczek K, Gasior M. Heyde syn­drome: gas­troin­testi­nal bleed­ing and aor­tic steno­sis. Cmaj. Feb 2 2016;188(2):135–138. doi:10.1503/cmaj.150194.
  11. Stortecky S, Buelles­feld L, Wenaweser P, et al. Atri­al fib­ril­la­tion and aor­tic steno­sis: impact on clin­i­cal out­comes among patients under­go­ing tran­scatheter aor­tic valve implan­ta­tion. Circ Car­dio­vasc Interv. Feb 2013;6(1):77–84. doi:10.1161/circinterventions.112.000124.
  12. Fag­giano P, Antoni­ni-Can­terin F, Ribi­chi­ni F, et al. Pul­monary artery hyper­ten­sion in adult patients with symp­to­matic valvu­lar aor­tic steno­sis. Am J Car­di­ol. Jan 15 2000;85(2):204–8. doi:10.1016/s0002-9149(99)00643–8
  13. Ger­sony WM, Hayes CJ, Driscoll DJ, et al. Bac­te­r­i­al endo­cardi­tis in patients with aor­tic steno­sis, pul­monary steno­sis, or ven­tric­u­lar sep­tal defect. Cir­cu­la­tion. Feb 1993;87(2 Suppl):I121‑6.
  14. Alas­nag M, AlMer­ri K, Almoghairi A, et al. One-Year Out­comes for Patients Under­go­ing Tran­scatheter Aor­tic Valve Replace­ment: The Gulf TAVR Reg­istry. Car­dio­vasc Revasc Med. 2022;41:19–26.
  15. Alas­nag M, Alanazi N, Al-Sheikh S, et al. WIN Gulf TAVR Reg­istry: Describ­ing Sex Dif­fer­ences in Patient Char­ac­ter­is­tics, Prog­no­sis, and Out­comes. JSCAI. 2022;doi:10.1016/j.jscai.2022.100509
  16. Alatawi FO, Abue­lat­ta RA, AlAhme­di AB, et al. Clin­i­cal out­comes with tran­scatheter aor­tic valve implan­ta­tion at a sin­gle car­diac cen­ter in Sau­di Ara­bia. Annals of Sau­di med­i­cine. 2018;38(3):167–173.
  17. Nko­mo VT, Gardin JM, Skel­ton TN, Gott­di­ener JS, Scott CG, Enriquez-Sara­no M. Bur­den of valvu­lar heart dis­eases: a pop­u­la­tion-based study. Lancet (Lon­don, Eng­land). Sep 16 2006;368(9540):1005–11. doi:10.1016/S0140-6736(06)69208–8
  18. De Scis­cio P, Bru­bert J, De Scis­cio M, Ser­rani M, Stasi­ak J, Mog­gridge GD. Quan­ti­fy­ing the shift toward tran­scatheter aor­tic valve replace­ment in low-risk patients: a meta-analy­sis. Cir­cu­la­tion: Car­dio­vas­cu­lar Qual­i­ty and Out­comes. 2017;10(6):e003287.
  19. Iung B, Vahan­ian A. Epi­demi­ol­o­gy of acquired valvu­lar heart dis­ease. Can J Car­di­ol. Sep 2014;30(9):962–70. doi:10.1016/j.cjca.2014.03.022.
  20. Strange GA, Stew­art S, Curzen N, et al. Uncov­er­ing the treat­able bur­den of severe aor­tic steno­sis in the UK. Open Heart. Jan 2022;9(1)doi:10.1136/openhrt-2021–001783.
  21. IPSOS. AS Patient Drop-off KSA. 2020.
  22. UNFPA and Hel­pAge Inter­na­tion­al. Coun­try pro­file: The rights and well­be­ing of old­er per­sons in Sau­di Ara­bia. 2015. https://arabstates.unfpa.org/sites/default/files/pub-pdf/country_profile_-_saudia_27-10–2021.pdf
  23. Hard­ing E BK, Mor­ris T, et al. Heart valve dis­ease: work­ing togeth­er to cre­ate a bet­ter patient jour­ney. 2022.
  24. Tar­ride J‑E, Lauck S, Natara­jan MK, Asgar AW, Luong T, Black­house G. One-year costs asso­ci­at­ed with hos­pi­tal­iza­tions due to aor­tic steno­sis in Cana­da. CJC open. 2021;3(1):82–90.
  25. Clark MA, Arnold SV, Duhay FG, et al. Five-year clin­i­cal and eco­nom­ic out­comes among patients with med­ical­ly man­aged severe aor­tic steno­sis: results from a Medicare claims analy­sis. Cir­cu­la­tion: Car­dio­vas­cu­lar Qual­i­ty and Out­comes. 2012;5(5):697–704.
  26. Trochu J‑N, Le Tourneau T, Oba­dia J‑F, Caran­hac G, Beres­ni­ak A. Eco­nom­ic bur­den of func­tion­al and organ­ic mitral valve regur­gi­ta­tion. Archives of car­dio­vas­cu­lar dis­eases. 2015;108(2):88–96.
  27. Rainò E, Rapali­no M, Mora­bito A. [Epi­demi­o­log­ic study in a Turin high-school]. Min­er­va Stom­a­tol. Jun 1988;37(6):505–6. Indagine epi­demi­o­log­i­ca in una scuo­la media di Tori­no.
  28. Ros­tag­no C. Heart valve dis­ease in elder­ly. World jour­nal of car­di­ol­o­gy. 2019;11(2):71.
  29. Mes­si­ka-Zeitoun D, Baum­gart­ner H, Bur­wash IG, et al. Unmet needs in valvu­lar heart dis­ease. Euro­pean heart jour­nal. 2023;doi:10.1093/eurheartj/ehad121.
  30. Mar­wick TH, Gall S, Bus­cut M, et al. Our Hid­den Age­ing: Time to Lis­ten to the Heart. 2018.
  31. Cen­ters for Dis­ease Con­trol and Pre­ven­tion. Valvu­lar Heart Dis­ease. Accessed June, 2023. https://www.cdc.gov/heartdisease/valvular_disease.htm#:~:text=If%20the%20heart%20valves%20are,stops%20beating)%2C%20and%20death.
  32. Iung B, Baron G, Butchart EG, et al. A prospec­tive sur­vey of patients with valvu­lar heart dis­ease in Europe: The Euro Heart Sur­vey on Valvu­lar Heart Dis­ease. Euro­pean heart jour­nal. 2003;24(13):1231–1243. doi:10.1016/s0195-668x(03)00201‑x
  33. Baum­gart­ner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guide­lines for the man­age­ment of valvu­lar heart dis­easeThe Task Force for the Man­age­ment of Valvu­lar Heart Dis­ease of the Euro­pean Soci­ety of Car­di­ol­o­gy (ESC) and the Euro­pean Asso­ci­a­tion for Car­dio-Tho­racic Surgery (EACTS). Euro­pean Jour­nal of Car­dio-Tho­racic Surgery.
  34. Amer­i­can Heart Asso­ci­a­tion. Aor­tic Steno­sis Overview. Accessed July, 2023. https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/heart-valve-problems-and-causes/problem-aortic-valve-stenosis
  35. Asa­mi M, Dob­n­er S, Stortecky S, et al. Car­dio­vas­cu­lar out­comes in patients with left atri­al enlarge­ment under­go­ing tran­scatheter aor­tic valve implan­ta­tion. Catheter Car­dio­vasc Interv. May 2022;99(6):1908–1917. doi:10.1002/ccd.30132
  36. Andreasen C, Gis­la­son GH, Køber L, et al. Inci­dence of ischemic stroke in indi­vid­u­als with and with­out aor­tic valve steno­sis: a Dan­ish ret­ro­spec­tive cohort study. Stroke. 2020;51(5):1364–1371.
  37. AlHabeeb W, Al-Ayoubi F, AlGha­layi­ni K, et al. Sau­di Heart Asso­ci­a­tion (SHA) guide­lines for the man­age­ment of heart fail­ure. Jour­nal of the Sau­di Heart Asso­ci­a­tion. 2019;31(4):204–253.
  38. Mayo Clin­ic. Tran­scatheter aor­tic valve replace­ment (TAVR). Accessed June, 2023. https://www.mayoclinic.org/tests-procedures/transcatheter-aortic-valve-replacement/about/pac-20384698.
  39. Cara­p­in­ha JL, Al-Omar HA, Alqoofi F, Samar­gandy SA, Can­dolfi P. Bud­get impact analy­sis of tran­scatheter aor­tic valve replace­ment in low, inter­me­di­ate, and high-risk patients with severe aor­tic steno­sis in Sau­di Ara­bia. J Med Econ. Dec 20 2021:1–16. doi:10.1080/13696998.2021.2020569.
  40. World Heart Fed­er­a­tion. Rheumat­ic Heart Dis­ease. Accessed July, 2023.
  41. Cleve­land Clin­ic. Rheumat­ic Heart Dis­ease. Accessed July, 2023. https://my.clevelandclinic.org/health/diseases/21485-rheumatic-heart-disease.
  42. Almad­hi AA, Alshamm­ri MR, Altami­mi NO, Hadal SA, Al Mad­hi AA, Salahie MS. Rheumat­ic Fever and Rheumat­ic Heart Dis­ease-Relat­ed Knowl­edge, Atti­tude, and Prac­tice in Sau­di Ara­bia. Cureus. Nov 2021;13(11):e19997. doi:10.7759/cureus.19997
  43. Bha­tia N, Bas­ra SS, Skol­nick AH, Wenger NK. Aor­tic valve dis­ease in the old­er adult. Jour­nal of Geri­atric Car­di­ol­o­gy: JGC. 2016;13(12):941.
  44. Mar­tins­son A, Li X, Ander­s­son C, Nils­son J, Smith JG, Sundquist K. Tem­po­ral trends in the inci­dence and prog­no­sis of aor­tic steno­sis: a nation­wide study of the Swedish pop­u­la­tion. Cir­cu­la­tion. Mar 17 2015;131(11):988–94. doi:10.1161/circulationaha.114.012906.
  45. Albuga­mi S, Al-Husayni F, Alfouti M, et al. Self-Expand­able Tran­scatheter Aor­tic Valve Implan­ta­tion Out­comes: Find­ings From the West­ern Region of Sau­di Ara­bia. Cureus. 2021;13(9).
  46. Danielsen R, Aspelund T, Har­ris TB, Gud­na­son V. The preva­lence of aor­tic steno­sis in the elder­ly in Ice­land and pre­dic­tions for the com­ing decades: The AGES–Reykjavík study. Inter­na­tion­al jour­nal of car­di­ol­o­gy. 2014;176(3):916–922.
  47. Gen­er­al Author­i­ty for Sta­tis­tics. https://www.stats.gov.sa/en
  48. Edward Life­sciences. Aor­tic Steno­sis Sur­vey for Pri­ma­ry Care Physi­cians results. 2023.
  49. Mik­ton C, de la Fuente-Núñez V, Offi­cer A, Krug E. Ageism: a social deter­mi­nant of health that has come of age. The Lancet. 2021;397(10282):1333–1334.
  50. Eber­stadt N. Heart Valve Dis­ease: Har­ness­ing Inno­va­tion to Save Lives, Mit­i­gate Costs, and Advance the Healthy Aging Agen­da. 2023;
  51. Gaede L, Sit­ges M, Neil J, et al. Euro­pean heart health sur­vey 2019. Clin­i­cal car­di­ol­o­gy. 2020;43(12):1539–1546.
  52. Bren­nan MJ, Coylewright M, Ayo-Vaughan M, Gane­san N. Bridg­ing gaps in heart valve dis­ease care: oppor­tu­ni­ties for qual­i­ty improve­ment. Catheter­i­za­tion and Car­dio­vas­cu­lar Inter­ven­tions. 2019;94(2):289–293.
  53. Mor­ris AA, Khaz­anie P, Drazn­er MH, et al. Guid­ance for time­ly and appro­pri­ate refer­ral of patients with advanced heart fail­ure: a sci­en­tif­ic state­ment from the Amer­i­can Heart Asso­ci­a­tion. Cir­cu­la­tion. 2021;144(15):e238-e250.
  54. Kir­by AM, Kruger B, Jain R, Daniel P, Granger BB. Using clin­i­cal deci­sion sup­port to improve refer­ral rates in severe symp­to­matic aor­tic steno­sis: a qual­i­ty improve­ment ini­tia­tive. CIN: Com­put­ers, Infor­mat­ics, Nurs­ing. 2018;36(11):525–529.
  55. Cham­bers JB, Lan­cel­lot­ti P. Heart Valve Clin­ics, Cen­ters, and Net­works. Car­di­ol Clin. Feb 2020;38(1):65–74. doi:10.1016/j.ccl.2019.09.006.
Pre­vi­ous pageNext page